Login to Your Account

Pharma: Other News To Note

Thursday, May 3, 2012
• Meda AB, of Goteborg, Sweden, said the FDA approved Dymista, a nasal spray formulation of azelastine hydrochloride and fluticasone propionate, for treatment of seasonal allergic rhinitis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription